8
Total investments
0
Early stage
1
Mid stage
3
Late stage
2y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investisseur
Feb 2025
BrainEver is a biopharmaceutical company developing a pipeline of novel therapies for patients with age-related neurodegenerative diseases, such as Charcot disease, Parkinson’s, and glaucoma, the second leading cause of blindness.
Our mission is to develop recombinant human Homeoproteins (HPs) to halt disease progression by stopping neuronal loss and durably restoring the physiology and metabolism of the remaining neurons.
BrainEver was co-founded by Bernard Gilly (iBionext) and Alain Prochiantz (Collège de France). Our innovative therapeutic approach stems from the pioneering work of Alain Prochiantz and his team on brain development and physiology.
Our lead project, BREN02, focuses on developing recombinant human Engrailed-1 (hEN1) for the treatment of patients with Amyotrophic Lateral Sclerosis (ALS).
Building on the highly promising results of our preclinical studies, we are preparing to launch clinical trials by 2025.
Follow us!
Investisseur
Dec 2024
Laboratory for the creation and production of custom-made 3D splints. The only fully recyclable splint in the world that allows you to go in the water. Super light, a cuff is around 150 grams and a boot around 300 grams. An adjustable and adjustable splint that allows you to see through for better medical follow-up. An unbeatable price, a splint accessible to all like a good old cast. Avoids any maceration, bad odors and itching.
Investisseur
Dec 2024
SHOP LES MEILLEURES MARQUES ENGAGÉES !
Et si mieux consommer devenait un jeu d’enfant ? Chaque matin : des marques à prix doux, des quiz, des défis, des cadeaux…
Et on na quune seule envie : vivre bien entourés.
Sans produit qui pique encore au cœur et au corps.
Notre raison dêtre : célébrer les marques bien fêtes.
Investisseur
Dec 2024
Seiki invents The Mobility Intelligence.
We designed powerful technologies & algorithms to reveal the true potential of population flows data.
For Brand Touchpoints & Advertisers, we dive into audiences and clusters mobility data to improve the impact on your target. We created a recognized MOOH ( Mobile Out of Home ) Audience Measurement methodology to assess the impact of a campaign before ( prediction ), during ( monitoring ) and after ( reporting ) it happens.
For companies in Retail & Real Estate we understand consumers on the move to optimize networks expansion.
For Institutions, we forecast population mouvements to design smart cities, predict and report congestion rates, draw mobility profiles...
Seiki unleashes the power of mobility intelligence, providing mouvement data that make sense.
Investisseur
Dec 2024
Rheological Solutions for Industry
Is the behavior of your products linked to their rheological properties? Do your industrial processes involve transporting materials by pipelines? Do you develop, mix, coat or pump materials as part of your industrial manufacturing processes?
Rheonova: recognized expertise and know-how in the field of rheology…
The characterisation of material fluids or pastes of differing structures:
functional polymers, suspensions, emulsions gels, etc
Studies to better understand complex rheological properties (shear thinning, shear thickening, thixotropy, viscoelasticity, yield stress, thermo dependence, piezo dependance)
Studies at every scale, from molecular to macroscopic
Development of flow studies under extreme conditions (pressure, temperature, high speed-flow, powerful magnetic fields)
Find out more about Rhéonova at www.rheonova.fr
Experience · 9 entries
All (9)
Investments (8)
Founder (1)
2025
Investisseur
Feb 2025
BrainEver is a biopharmaceutical company developing a pipeline of novel therapies for patients with age-related neurodegenerative diseases, such as Charcot disease, Parkinson’s, and glaucoma, the second leading cause of blindness.
Our mission is to develop recombinant human Homeoproteins (HPs) to halt disease progression by stopping neuronal loss and durably restoring the physiology and metabolism of the remaining neurons.
BrainEver was co-founded by Bernard Gilly (iBionext) and Alain Prochiantz (Collège de France). Our innovative therapeutic approach stems from the pioneering work of Alain Prochiantz and his team on brain development and physiology.
Our lead project, BREN02, focuses on developing recombinant human Engrailed-1 (hEN1) for the treatment of patients with Amyotrophic Lateral Sclerosis (ALS).
Building on the highly promising results of our preclinical studies, we are preparing to launch clinical trials by 2025.
Follow us!
Investisseur
Jan 2025
Were hiring worldwide!
https://wandercraft.welcomekit.co/
At Wandercraft, we believe movement is freedom. Since 2012, our mission has been simple but bold: restore mobility where it’s been lost, and expand what’s possible with robotics that move like people do.
We see robotics as the ultimate partners—machines that can do what humans cannot, or should not, do. That means giving back the ability to walk to someone with a spinal cord injury, or stepping in on a factory floor where work is too heavy, repetitive, or hazardous.
We pioneered the world’s first self-balancing exoskeleton—technology that doesn’t rely on crutches or walkers, but lets people stand and walk freely. Today, our work goes beyond healthcare. From rehabilitation centers to factory floors, and soon into homes and communities, we’re shaping a future where humans and robots move forward together.
Our technology, powered by physical AI and 30+ patents, is life-tested in the most demanding environments: real people, real steps, real work.
Meet our devices:
Atalante X – A self-balancing exoskeleton enabling hundreds of patients with mobility disabilities to take over 1 million steps per month in 100+ leading hospitals and research centers worldwide. It is designed to promote upright posture, cardiovascular health, neuroplasticity, and—most importantly—upright independence.
Eve – The world’s first self-balancing exoskeleton for personal use. Designed for daily life, Eve enables individuals with severe mobility impairments to walk hands-free at home and outdoors. Currently in U.S. clinical trials, Eve is expected to launch in 2026.
Calvin-40 – Our first industrial humanoid robot. Autonomous and voice-operated, Calvin-40 is built to take on physically demanding or hazardous tasks in non-ergonomic environments. Based on the same platform as our exoskeletons, Calvin is already hard at work with Renault Group and more.
2024
Investisseur
Dec 2024
Laboratory for the creation and production of custom-made 3D splints. The only fully recyclable splint in the world that allows you to go in the water. Super light, a cuff is around 150 grams and a boot around 300 grams. An adjustable and adjustable splint that allows you to see through for better medical follow-up. An unbeatable price, a splint accessible to all like a good old cast. Avoids any maceration, bad odors and itching.
Investisseur
Dec 2024
SHOP LES MEILLEURES MARQUES ENGAGÉES !
Et si mieux consommer devenait un jeu d’enfant ? Chaque matin : des marques à prix doux, des quiz, des défis, des cadeaux…
Et on na quune seule envie : vivre bien entourés.
Sans produit qui pique encore au cœur et au corps.
Notre raison dêtre : célébrer les marques bien fêtes.
Show all 9 entries ↓
Investment activity
2024–2025 · 8 investments
Recent (last 2 years)Earlier
